Shanghai Yizhong Pharmaceutical Co., Ltd. (SHA:688091)
China · Delayed Price · Currency is CNY 51.46
+2.58 (5.28%)
Feb 3, 2026, 3:00 PM CST
Shanghai Yizhong Pharmaceutical Company Description
Shanghai Yizhong Pharmaceutical Co., Ltd. engages in the development of anti-tumor drugs and related products in China.
It also offers paclitaxel polymer nanomicelles for the treatment of non-small cell lung cancer, as well as various types of cancer, including esophageal cancer, gastric cancer, nasopharyngeal carcinoma, pancreatic cancer, breast cancer, gynecological tumors, etc. The company was founded in 2009 and is headquartered in Shanghai, China.
Shanghai Yizhong Pharmaceutical Co., Ltd.
| Country | China |
| Founded | 2009 |
| Industry | Drug Manufacturers - Specialty & Generic |
| Sector | Healthcare |
| Employees | 415 |
| CEO | Jingsong Zhou |
Contact Details
Address: No.79 Renqi Road Shanghai, 201401 China | |
| Phone | 86 21 3719 0005 |
| Website | yizhongpharma.com |
Stock Details
| Ticker Symbol | 688091 |
| Exchange | Shanghai Stock Exchange |
| Fiscal Year | January - December |
| Reporting Currency | CNY |
| ISIN Number | CNE1000050F4 |
| SIC Code | 2834 |
Key Executives
| Name | Position |
|---|---|
| Jingsong Zhou | Chairman and GM |
| Zhiyuan Zhang | Financial Director |
| Duan Li | Deputy GM and Director |
| Jing Sun | Deputy GM and Director |
| Zhou Fang | Board Secretary |
| Wenming Zhang | Deputy General Manager |
| Tian Ruan | Accounting Supervisor |
| Xin Ran Meng | Employee Supervisor and Deputy Manager of Human Resources Department |